Literature DB >> 2966564

"High-risk" percutaneous transluminal coronary angioplasty.

G O Hartzler1, B D Rutherford, D R McConahay, W L Johnson, L V Giorgi.   

Abstract

Of 6,500 percutaneous transluminal coronary angioplasty procedures performed between June 1980 and June 1987, 3,501 (1,604 single lesion and 1,897 multiple lesion) were performed in "low-risk" patients with a procedure-related mortality of 0.2 to 0.3%. In comparison, several clinical variables were identified that increased procedural risk by up to 50-fold. These factors include left main dilatation (n = 103, mortality 3.9%), left main equivalent dilatation (n = 77, mortality 2.6%), ejection fraction less than or equal to 40% (n = 664, mortality 2.7%), age greater than or equal to 70 years (n = 1,038, mortality 1.4%), dilatation of all 3 vessels (n = 305, mortality 1.3%), combined diagnostic catheterization and angioplasty for unstable angina (n = 193, mortality 1.5%), and percutaneous transluminal coronary angioplasty for acute myocardial infarction (n = 446, mortality 8.5%). Important considerations in the selection and management of these high-risk patients are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 2966564     DOI: 10.1016/s0002-9149(88)80030-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Myocardial protection during coronary angioplasty.

Authors:  P Angelini; D R Leachman; G Disciascio; M J Cowley; J A Brinker
Journal:  Tex Heart Inst J       Date:  1992

2.  Percutaneous transluminal coronary angioplasty using kissing balloon technique in the left main trunk.

Authors:  S Nanto; K Kodama; M Mishima; K Komamura; S Asada; M Inoue
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

3.  Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.

Authors:  Giuseppe Biondi-Zoccai; Imad Sheiban; Claudio Moretti; Tullio Palmerini; Antonio Marzocchi; Davide Capodanno; Corrado Tamburino; Massimo Margheri; Giuseppe Vecchi; Giuseppe Sangiorgi; Andrea Santarelli; Antonio L Bartorelli; Carlo Briguori; Luigi Vignali; Francesco di Pede; Angelo Ramondo; Massimo Medda; Marco de Carlo; Giovanni Falsini; Alberto Benassi; Cataldo Palmieri; Vincenzo Filippone; Diego Sangiorgi; Fabio Barlocco; Stefano de Servi
Journal:  Clin Res Cardiol       Date:  2010-12-03       Impact factor: 5.460

4.  High-risk coronary angioplasty assisted by active hemoperfusion. A feasibility study.

Authors:  P Angelini; C Hernandez; J J Ferguson; R D Leachman; J A Garcia-Gregory; J Benrey; M J Schnee; S F Fighali; Z Krajcer
Journal:  Tex Heart Inst J       Date:  1996

5.  Debate: Unstable angina - When should we intervene?

Authors:  Dean J Kereiakes
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

Review 6.  Advanced nanomaterials targeting hypoxia to enhance radiotherapy.

Authors:  Jia Li; Wenting Shang; Yong Li; Sirui Fu; Jie Tian; Ligong Lu
Journal:  Int J Nanomedicine       Date:  2018-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.